Viatris (VTRS) Interest Coverage Ratio: History & Chart

Viatris Inc. (VTRS)VTRSViatris Inc.

About Viatris Inc.

Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus on critical conditions in oncology, immunology, endocrinology, ophthalmology, and dermatology. Furthermore, Viatris's APIs are utilized across numerous drug categories, including antibacterials, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors. Beyond manufacturing medicines, Viatris supports patient well-being through additional services such as diagnostic clinics, educational seminars, and digital tools designed to assist with health management. Products are made available in various forms, including oral solids, injectable solutions, complex dosage formulations, and raw APIs. Viatris distributes these to a broad clientele globally, including retail pharmacies, wholesalers, government bodies, insurance providers, and institutional healthcare facilities. The distribution network involves pharmaceutical wholesalers, retail and institutional pharmacies, mail-order and e-commerce platforms, and specialty pharmacies. The company's extensive portfolio includes prominent brands like Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, Yupelri, Norvasc, Viagra, AMITIZA, Lipacreon, Effexor, Celebrex, and ARV. Its biosimilar franchises feature products such as Fulphila, Ogivri, Hulio, and SEMGLEE. Viatris Inc. also fosters innovation through strategic collaborations and licensing agreements with partners including Revance Therapeutics, Inc., Momenta Pharmaceuticals, Inc., Theravance Biopharma, Inc., Biocon Ltd., and Fujifilm Kyowa Kirin Biologics Co. Ltd. Founded in 1961, Viatris Inc. maintains its corporate headquarters in Canonsburg, Pennsylvania.

Canonsburg, PA

30,000 employees

www.viatris.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Scott Andrew Smith

View full financials

VTRS Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-0.66x

INTEREST COVERAGE RATIO AVG TTM

-4.75x

INTEREST COVERAGE RATIO AVG 3Y

0.53x

INTEREST COVERAGE RATIO AVG 5Y

0.86x

INTEREST COVERAGE RATIO AVG 10Y

1.36x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+86.02%

CURRENT VS 3Y AVG

-225.26%

CURRENT VS 5Y AVG

-177.10%

CURRENT VS 10Y AVG

-148.76%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

6.77x

median of 73 covered companies

CURRENT VS SECTOR MEDIAN

-109.80%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Viatris Inc. (VTRS)	$20.55B	-0.66x	-4.75x	0.53x	0.86x
United Therapeutics Corporation (UTHR)vs ›	$22.03B	77.81x	54.95x	40.03x	35.88x
Zimmer Biomet Holdings, Inc. (ZBH)vs ›	$18.99B	4.65x	5.28x	5.28x	4.27x
Moderna, Inc. (MRNA)vs ›	$22.32B	-307.40x	531.75x	531.75x	531.75x
STERIS plc (STE)vs ›	$22.68B	18.15x	14.10x	10.28x	10.20x
BioNTech SE (BNTX)vs ›	$23.16B	-45.74x	444.02x	1201.03x	1201.03x
Hologic, Inc. (HOLX)vs ›	$16.97B	16.73x	11.98x	11.81x	13.87x
Incyte Corporation (INCY)vs ›	$24.28B	553.04x	298.73x	269.07x	276.66x
Medpace Holdings, Inc. (MEDP)vs ›	$16.41B	N/A	393.08x	892.58x	554.26x
West Pharmaceutical Services, Inc. (WST)vs ›	$24.72B	1029.00x	617.01x	353.82x	258.97x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Viatris Inc. (VTRS)

$20.55B

-0.66x

-4.75x

0.53x

0.86x

United Therapeutics Corporation (UTHR)vs ›

$22.03B

77.81x

54.95x

40.03x

35.88x

Zimmer Biomet Holdings, Inc. (ZBH)vs ›

$18.99B

4.65x

5.28x

4.27x

Moderna, Inc. (MRNA)vs ›

$22.32B

-307.40x

531.75x

STERIS plc (STE)vs ›

$22.68B

18.15x

14.10x

10.28x

10.20x

BioNTech SE (BNTX)vs ›

$23.16B

-45.74x

444.02x

1201.03x

Hologic, Inc. (HOLX)vs ›

$16.97B

16.73x

11.98x

11.81x

13.87x

Incyte Corporation (INCY)vs ›

$24.28B

553.04x

298.73x

269.07x

276.66x

Medpace Holdings, Inc. (MEDP)vs ›

$16.41B

N/A

393.08x

892.58x

554.26x

West Pharmaceutical Services, Inc. (WST)vs ›

$24.72B

1029.00x

617.01x

353.82x

258.97x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Viatris Inc. (VTRS)?

The interest coverage ratio for VTRS stock is -0.66x.

Is Viatris Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -0.66x is 80% below its 5-year average of -0.37x, near the high end of its 5-year range (-24.95x–4.84x).

What is the TTM average interest coverage ratio for Viatris Inc. (VTRS)?

The TTM average interest coverage ratio for VTRS stock is -4.75x.

What is the 3Y average interest coverage ratio for Viatris Inc. (VTRS)?

The 3Y average interest coverage ratio for VTRS stock is 0.53x.

What is the 5Y average interest coverage ratio for Viatris Inc. (VTRS)?

The 5Y average interest coverage ratio for VTRS stock is 0.86x.

What is the 10Y average interest coverage ratio for Viatris Inc. (VTRS)?

The 10Y average interest coverage ratio for VTRS stock is 1.36x.

DATE	INTEREST COVERAGE RATIO
2026-03-31	-0.66x
2025-12-31	-2.22x
2025-09-30	2.10x
2025-06-30	2.00x
2025-03-31	-24.95x
2024-12-31	-1.50x
2024-09-30	1.55x
2024-06-30	-1.65x
2024-03-31	1.47x
2023-12-31	-3.23x
2023-09-30	3.19x
2023-06-30	2.57x
2023-03-31	2.72x
2022-12-31	-1.37x
2022-09-30	3.66x
2022-06-30	3.76x
2022-03-31	4.84x
2021-12-31	-0.52x
2021-09-30	2.35x
2021-06-30	-0.29x
2021-03-31	-1.58x
2020-12-31	-6.10x
2020-09-27	3.00x
2020-06-28	1.15x
2020-03-29	1.54x
2019-12-31	2.16x
2019-09-29	2.51x
2019-06-29	0.73x
2019-03-30	0.18x
2018-12-30	1.72x
2018-09-29	2.48x
2018-06-29	1.29x
2018-03-30	1.18x
2017-12-30	3.28x
2017-09-29	2.40x
2017-06-29	3.48x
2017-03-30	1.65x
2016-12-30	2.11x
2016-09-29	-0.91x
2016-06-29	4.55x
2016-03-30	1.50x
2015-12-30	5.98x
2015-09-29	6.32x
2015-06-29	2.95x
2015-03-30	2.00x
2014-12-30	4.79x
2014-09-29	5.90x
2014-06-29	2.67x
2014-03-30	2.89x
2013-12-30	3.43x
2013-09-29	4.60x

DATE

INTEREST COVERAGE RATIO

2026-03-31

-0.66x

2025-12-31

-2.22x

2025-09-30

2.10x

2025-06-30

2.00x

2025-03-31

-24.95x

2024-12-31

-1.50x

2024-09-30

1.55x

2024-06-30

-1.65x

2024-03-31

1.47x

2023-12-31

-3.23x

2023-09-30

3.19x

2023-06-30

2.57x

2023-03-31

2.72x

2022-12-31

-1.37x

2022-09-30

3.66x

2022-06-30

3.76x

2022-03-31

4.84x

2021-12-31

-0.52x

2021-09-30

2.35x

2021-06-30

-0.29x

2021-03-31

-1.58x

2020-12-31

-6.10x

2020-09-27

3.00x

2020-06-28

1.15x

2020-03-29

1.54x

2019-12-31

2.16x

2019-09-29

2.51x

2019-06-29

0.73x

2019-03-30

0.18x

2018-12-30

1.72x

2018-09-29

2.48x

2018-06-29

1.29x

2018-03-30

1.18x

2017-12-30

3.28x

2017-09-29

2.40x

2017-06-29

3.48x

2017-03-30

1.65x

2016-12-30

2.11x

2016-09-29

-0.91x

2016-06-29

4.55x

2016-03-30

1.50x

2015-12-30

5.98x

2015-09-29

6.32x

2015-06-29

2.95x

2015-03-30

2.00x

2014-12-30

4.79x

2014-09-29

5.90x

2014-06-29

2.67x

2014-03-30

2.89x

2013-12-30

3.43x

2013-09-29

4.60x

Interest Coverage Ratio: -0.66x

VTRS Interest Coverage Ratio

VTRS Average Interest Coverage Ratio Chart

VTRS Current vs Average Interest Coverage Ratio Chart

VTRS Interest Coverage Ratio Metrics

VTRS Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

VTRS Interest Coverage Ratio History

Related Metrics